Successful Aortic Valve Replacement in Severe Pancytopenia Related to Myelodysplastic Syndrome

Japanese Journal of Thoracic and Cardiovascular Surgery

Volumn 51, Issue 2, 2003, Pages 77-80

  Kurisu, Kazuhiro ^a   Ochiai, Yoshie ^a   Kajiwara, Takashi ^a   Tominaga, Ryuji ^a  

^a KITAKYUSHU MUNICIPAL MEDICAL CENTER   (Japan)

Author keywords

Granulocyte colony stimulating factor; Myelodysplastic syndrome; Open heart surgery; Pancytopenia

Indexed keywords

ANTIBIOTIC AGENT; ANTIFIBRINOLYTIC AGENT; CEFAZOLIN; DIBEKACIN; GRANULOCYTE COLONY STIMULATING FACTOR; THROMBOCYTE CONCENTRATE; TRANEXAMIC ACID;

ADULT; AORTA STENOSIS; AORTA VALVE REPLACEMENT; BONE MARROW EXAMINATION; CASE REPORT; CONFERENCE PAPER; DISEASE SEVERITY; DYSPNEA; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HUMAN; HUMAN CELL; MALE; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; PANCYTOPENIA; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; SURGICAL RISK; SURGICAL TECHNIQUE; AORTA VALVE; AORTA VALVE STENOSIS; ARTICLE; BIOPROSTHESIS; HEART VALVE REPLACEMENT; MIDDLE AGED;

AORTIC VALVE; AORTIC VALVE STENOSIS; BIOPROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PANCYTOPENIA;

EID: 0037608850     PISSN: 13444964     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02719174     Document Type: Conference Paper

References (9)

1. Noël P, Solberg LA Jr. Myelodysplastic syndromes. Pathogenesis, diagnosis and treatment. Crit Rev Oncol Hematol 1992; 12: 193-215.
2. Yamagishi T, Fuse K, Saito T, Kato M, Misawa Y, Kamisawa O, et al. Successful coronary artery bypass grafting for a patient with myelodysplastic syndrome: report of a case. Surg Today 1996; 26: 740-3.
3. Okamura T, Kou E, Yokoyama S, Kunii Y, Kitamura M, Matsumuro A, et al. A case report of mitral valve replacement in a patient with MDS (RAEB-t) and mitral valve regurgitation (in Japanese). Shinnzou 1999; 31: 33-5.
4. Miyagi Y, Yamauchi S, Suzuki S, Kitagawa A, Masaki Y, Gomibuchi M, et al. Investigation of coronary artery bypass grafting for a patient with myelodysplastic syndrome. Ann Thorac Cardiovasc Surg 2001; 7: 250-3.
5. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-99.
6. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079-88.
7. Yoshida Y, Hirashima K, Asano S, Takaku F. A phase II trial of recombinant human granulocyte colony-stimulating factor in the myelodysplastic syndromes. Br J Haematol 1991; 78: 378-84.
8. American Society of Clinical Oncology. Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. J Clin Oncol 1996; 14: 1957-60.
9. Casati V, Guzzon D, Oppizzi M, Bellotti F, Franco A, Gerli C, et al. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions. J Thorac Cardiovasc Surg 2000; 120: 520-7.